SCHEMBL20113633

SCHEMBL20113633

C=C(CC(=O)SCc1ccccc1)P1(=N)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 4/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
IDO1 P14902 6/20 0.34
METAP2 P50579 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
LMNA P02545 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 3/20 0.33
TP53 P04637 1/20 0.33
MAPK1 P28482 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TSHR P16473 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109244 0.87 HDAC3 (0.33) MAPTRAB9ANPC1SMN1; SMN2LMNA
SCHEMBL20109345 0.87 TDP1 (0.39) TDP1L3MBTL1MAPTRAB9ANPC1
SCHEMBL20113433 0.86 TDP1 (0.38) TDP1L3MBTL1MAPTRAB9ANPC1
SCHEMBL20113532 0.75 MAPT (0.40) L3MBTL1MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL20109144 0.73 NPSR1 (0.32) MAPTLMNAKMT2AALDH1A1MAPK1
SCHEMBL20109257 0.72 ALDH1A1 (0.33) L3MBTL1MAPTRAB9ANPC1LMNA
SCHEMBL20113730 0.72 TDP1 (0.41) TDP1L3MBTL1SMN1; SMN2IDO1NOS3
SCHEMBL20113399 0.72 TDP1 (0.44) TDP1L3MBTL1SMN1; SMN2IDO1NOS3
SCHEMBL20109230 0.72 GAA (0.34) MAPTLMNAKMT2AALDH1A1KDM4E
SCHEMBL6963636 0.72 TDP1 (0.59) TDP1L3MBTL1SMN1; SMN2IDO1NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10633403-B2 N-heterocyclic phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA (US) 2020-04-28 US disclosed
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 TDP1 2513/4885L3MBTL1 3799/4885MAPT 4371/4885
US-10633403-B2 N-heterocyclic phosphines NANP, PPIP5K2, PHPT1 TDP1 2513/4885L3MBTL1 3799/4885MAPT 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.